DIRS.INFO The most relevant business & tech news

☆ Patients and staff were stranded at a flooded Tennessee hospital
▼ + stars: | 2024-09-27 | by ( Deon J. Hampton | Deon J. Hampton Is A National Reporter For Nbc News. | ) www.nbcnews.com time to read: +2 min

More than 50 people were stranded Friday at an eastern Tennessee hospital due to fast-rising water and high winds, after several attempts to airlift them failed during a dangerous rescue operation, Ballad Health officials said. The high winds and water levels prevented helicopter crews from airlifting patients and staff from Unicoi County Hospital in Erwin, Tennessee, hospital officials said. “The situation at the hospital is very dangerous,” Ballad Health said on X, adding the Tennessee Emergency Management Agency and National Guard were engaged “in what can only be described as a dangerous rescue operation.”Patients and staff members are evacuated from Unicoi County Hospital on Friday. County leaders in Unicoi initially deployed ambulances but unusually high flooding prevented medics from safely approaching, Ballad Health said. The Tennessee Emergency Management Agency has been working with local emergency management agencies to deploy boats for hospital evacuations, but water surrounding and entering the building became dangerous and impassable.

Persons: Regan Tilson, “ We’ve, ”, Patrick Sheehan, Hurricane Helene Organizations: Health, Tennessee Emergency Management Agency, National Guard, Erwin, TEMA, Virginia State Police, Emergency Management Agency Locations: Tennessee, Unicoi, Erwin , Tennessee, Georgia

☆ Nvidia may be the AI darling, but it's time to start looking at this chip stock, one CIO says
▼ + stars: | 2024-09-10 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +2 min

Tema ETFs' Yuri Khodjamirian is keeping a close watch on chip designer Qualcomm Inc . As AI shifts from data centers — an Nvidia "stronghold" — to the " edge ," investors should "start looking at companies like Qualcomm," Khodjamirian said. And "edge AI" is more than about chips — "it's really everything, the silicon content of our mobile phones and PCs, has to go up, because you need better memory; you need better connectivity between the different semiconductors. Qualcomm's shares are currently trading at around 15.3 times forward earnings, while Nvidia has a multiple of around 38, according to FactSet data. 'Emerging Edge AI play' Analysts at KeyBanc Capital Markets are bullish on Qualcomm and have a target price of $225 on the stock, or 55.8% upside.

Persons: Yuri Khodjamirian, CNBC's, It's, Khodjamirian, Cristiano Amon, Leswing, Arjun Kharpal, Michael Bloom Organizations: Nvidia, Qualcomm Inc, Qualcomm, Samsung, Nasdaq, CNBC, Google, KeyBanc Locations: Tema

☆ Eli Lilly reports earnings Thursday. Here's what Wall Street is watching
▼ + stars: | 2024-08-07 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +5 min

Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street's expectations. While Eli Lilly's stock remains up about 32% year to date, concerns about increasing competition in the category have resulted in a nearly 16% decline for Lilly shares over the past month. Eli Lilly is making similar attempts with Zepbound, but its launch is at an earlier stage than Wegovy. Second-quarter sales of Ozempic, Novo's diabetes treatment, rose 4% from the first quarter, while Wegovy revenue grew 24% quarter over quarter. Barclays analyst Emily Field told clients in a research note that she would be a buyer of Novo Nordisk shares on the weakness.

Persons: Eli Lilly, Eli, Lilly, Wells, Mohit Bansal, Ozempic, Bansal, Emily Field, David Song, Song, Chris Schott, Schott Organizations: Novo Nordisk, LSEG, Lilly's, Management, Food and Drug Administration, Barclays, Tema, JPMorgan Locations: Wells Fargo, IQVIA, Amgen, MariTide, Novo, CagriSema

☆ These 4 companies — including one backed by Warren Buffett — can leverage AI with their exclusive data, says fund manager
▼ + stars: | 2024-07-30 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

AI models, such as OpenAI's ChatGPT or Anthropic's Claude, are built by running complex algorithms on large amounts of data. Khodjamirian, who also manages the Monopolies and Oligopolies ETF , named four stocks that he sees as potential winners: Moody's , S & P Global , MSCI , and Intuit . Moody's Using Moody's as a prime example, the fund manager highlighted the company's extensive database on credit decisions. MCO 5Y line S & P Global and MSCI Similarly, Khodjamirian sees potential in S & P Global and MSCI due to their vast troves of financial and index data. His thesis rests on the idea that as AI use becomes more widespread, the value of software — the AI models — may diminish.

Persons: Yuri Khodjamirian, Claude, Khodjamirian, CNBC's, Moody's, they're, Warren Buffett's Berkshire Hathaway, MCO, Meta, Warren Buffett's Organizations: Tema ETF's, P, Intuit, Facebook, Microsoft Locations: Tema, Moody's

☆ CNBC Daily Open: Asian shares slide, U.S. stocks flat ahead of Big Tech earnings; McDonald's earnings miss
▼ + stars: | 2024-07-30 | by ( Kevin Lim | ) www.cnbc.com time to read: +3 min

CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. McDonald's missMcDonald's quarterly earnings and revenue fell short of analysts' expectations as same-store sales declined globally for the first time since 2020. The fast-food giant's second-quarter net income fell to $2.02 billion from $2.31 billion a year ago, while revenue was nearly flat at $6.49 billion. Asia stocks weakenAsian stocks traded lower as the Bank of Japan began a two-day meeting where it is widely expected to raise benchmark interest rates. Japan central bank meetsThe Bank of Japan began its two-day policy meeting Tuesday amid expectations of an interest rate hike.

Persons: McDonald's, iPhones, Seng, Fortescue, JPMorgan, Yuri Khodjamirian, CNBC's Organizations: CNBC, Nasdaq, Big Tech, Dow Jones Industrial, Treasury, Hezbollah, Apple, Apple Intelligence, Max, Bank of Japan, Nikkei, CSI, Australian Financial Review, Tema Locations: U.S, Israel, Iran, Lebanon, Asia, Australia, Japan

☆ Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says
▼ + stars: | 2024-07-26 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

Weight loss drugs have drawn investor interest and shaken up other sectors in the past year or so. Novo Nordisk and Eli Lilly were two early winners of this trend, as their drugs dominate the weight loss drug market. Yuri Khodjamirian, fund manager at Tema ETFs, said both companies are a "very powerful duopoly." They're a lot more risky than the bigger ones who already have drugs on the market," Khodjamirian said. Tema ETFs offers actively managed exchange-traded funds, with a focus on health care and life sciences.

Persons: Eli Lilly, Yuri Khodjamirian, Goldman Sachs, Khodjamirian, Roche Organizations: Novo Nordisk, Tema, CNBC, Zealand Pharma, Viking Therapeutics, Tema Oncology, Mental Health Locations: Tema

☆ European luxury giants send warning signals around consumer spending
▼ + stars: | 2024-07-25 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEuropean luxury giants send warning signals around consumer spendingJavier Gonzalez Lastra, Investment Partner and Portfolio Manager at TEMA ETFs, discusses weak earnings from LVMH, Kering, and other luxury giants.

Persons: Javier Gonzalez Lastra Organizations: Investment Locations: TEMA, LVMH

☆ These 2 stocks and an ETF will gain whoever wins the U.S. election, says fund manager
▼ + stars: | 2024-07-23 | by ( Ganesh Rao | ) www.cnbc.com time to read: +3 min

As the United States presidential election nears, there's one key theme that's expected to continue regardless of who wins: the reshoring of American manufacturing . Tema ETFs runs the actively managed American Reshoring ETF (ticker RSHO), designed to take advantage of this trend. "The American reshoring fund is built on the foundation that the world's not getting any safer. However, the fund manager cautioned that there could be challenges in hiring skilled labor due to the decline in the United States semiconductor manufacturing industry over the years. TSM 5Y line While TSMC is less than 1% of the American Reshoring ETF, Clean Harbors is a top 10 holding with 4.71% allocated.

Persons: Yuri Khodjamirian, CNBC's, PFAS —, Khodjamirian Organizations: United, Republicans, Democrats, Tema, American, Harbors, Clean Harbors, Taiwan Semiconductor, ETF Locations: United States, Tema, North America, Arizona

☆ CNBC Pro Talks: From weight loss drugs to AI winners, CIO reveals his top stocks
▼ + stars: | 2024-07-17 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCNBC Pro Talks: From weight loss drugs to AI winners, CIO reveals his top stocksWeight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside. CNBC’s Senior Technology Correspondent Arjun Kharpal spoke to Tema ETFs’ Yuri Khodjamirian on how to best invest in these areas.

Persons: Arjun Kharpal, Yuri Khodjamirian Locations: Tema

☆ CNBC Pro Talks: From weight loss drugs to AI winners, CIO set to reveal his top stocks
▼ + stars: | 2024-07-16 | by ( ) www.cnbc.com time to read: +2 min

Weight loss drugs and artificial intelligence have been dominating headlines, with investors betting that stocks in both categories have big potential upside. On Wednesday's Pro Talks , CNBC's Senior Technology Correspondent Arjun Kharpal will ask Tema ETFs' Yuri Khodjamirian how to best invest in these areas and more. Tema ETFs offers actively managed ETFs, with a focus on healthcare and life sciences. Before Tema ETFs, Khodjamirian spent over a decade at Majedie Asset Management, overseeing U.K. and global portfolios. Click here to join CNBC Pro Talks on Wednesday, July 17, at 7 a.m.

Persons: Arjun Kharpal, Yuri Khodjamirian, Eli Lilly, he'll, Khodjamirian Organizations: Tema, Novo Nordisk, pharma, Majedie Asset Management, Income, CNBC, Nvidia, Scotiabank Locations: Tema, —, U.S, U.K, India

☆ This ETF is trying to satisfy appetites for weight loss stocks
▼ + stars: | 2024-07-06 | by ( Ellie Stevens | ) www.cnbc.com time to read: 1 min

Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. The firm's founder and CEO Maurits Pot thinks the winning weight loss trade isn't based on just hype. "We could see a world where the majority of the world's population takes a GLP-1, not just for weight loss, but for other diseases." His top holdings include Mounjaro manufacturer Eli Lilly and Ozempic and Wegovy maker Novo Nordisk. Eli Lilly is up 57% so far this year, while Novo Nordisk is up 38%.

Persons: Maurits Pot, Pot, Eli Lilly, Ozempic Organizations: Cardiometabolic, Novo Nordisk Locations: Tema, Novo

☆ 'Early innings' of a U.S. manufacturing boom: Tema ETFs CEO delivers bull case for industrials
▼ + stars: | 2024-07-03 | by ( Emily Glass | ) www.cnbc.com time to read: 1 min

One exchange-traded fund is betting on a U.S. manufacturing job resurgence. Tema ETFs CEO and founder Maurits Pot is behind the American Reshoring ETF (RSHO) that focuses on industrials. "At the heart of it is job creation, manufacturing and reshoring — bringing back local manufacturing jobs." Pot's firm launched the American Reshoring ETF in May 2023. Since its inception, the exchange-traded fund is up almost 37% as of Wednesday's close.

Persons: Maurits Pot, Pot, — Organizations: Reshoring, American, ETF Locations: U.S, Tema, We're

☆ Tema CEO Maurits Pot on capturing a reshoring rebound
▼ + stars: | 2024-07-01 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTema CEO Maurits Pot on capturing a reshoring reboundMaurits Pot, founder & CEO of Tema, joins ‘Halftime Report’ on ‘ETF Edge’ to discuss how the upcoming U.S. election will affect "reshoring" and the ETFs that follow it.

Persons: Maurits Pot Organizations: Tema Locations: Tema

☆ Weight loss now its own segment... with its own ETFs?
▼ + stars: | 2024-07-01 | by ( Bob Pisani | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWeight loss now its own segment... with its own ETFs? Maurits Pot, Tema CEO and founder, joins CNBC's Bob Pisani on 'ETF Edge' to discuss the company's GLP-1, Obesity and Cardiometabolic ETF, which invests in weight loss stocks. Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.

Persons: Maurits, Bob Pisani, Todd Sohn Organizations: Tema, Technical Locations: Maurits Pot

☆ ETF Edge, July 1, 2024
▼ + stars: | 2024-07-01 | by ( Bob Pisani | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailETF Edge, July 1, 2024Maurits Pot, Tema CEO and founder, joins CNBC's Bob Pisani on 'ETF Edge' to discuss the company's GLP-1, Obesity and Cardiometabolic ETF and American Reshoring ETF. Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.

Persons: Maurits Pot, Bob Pisani, Todd Sohn Organizations: Tema, American Reshoring, Technical

☆ Is "inshoring" ready for revolution?
▼ + stars: | 2024-07-01 | by ( Bob Pisani | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailIs "inshoring" ready for revolution? Maurits Pot, Tema CEO and founder, joins CNBC's Bob Pisani on 'ETF Edge' to discuss the company's American Reshoring ETF, which invests in industrial and infrastructure companies. Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.

Persons: Maurits, Bob Pisani, Todd Sohn Organizations: Tema, ETF, Technical Locations: Maurits Pot

☆ Which sectors and stocks could benefit the most from "near-shoring"
▼ + stars: | 2024-06-27 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWhich sectors and stocks could benefit the most from "near-shoring"Maurits Pots, CEO of Tema ETFs, discusses how even an incremental increase in investment in U.S. manufacturing capacity could benefit a select group of companies and the economy as a whole.

Persons: Maurits Locations: Tema

☆ 'Blew my mind': Investor says one key stat shows Nvidia is in it for the long haul
▼ + stars: | 2024-06-10 | by ( Ganesh Rao | ) www.cnbc.com time to read: +2 min

"The stat that really blew my mind is that the forecast cash flow for Nvidia for 2026 is higher than Microsoft ," Yuri Khodjamirian, CIO at Tema ETFs, told CNBC's Squawk Box Europe, emphasizing the remarkable growth trajectory of Nvidia. This projection is driven by the surging demand for Nvidia's AI chips, as software companies increasingly rely on these powerful processors to fuel their artificial intelligence models. The spending by software giants such as Microsoft , Amazon and Google is propelling the share prices of Nvidia and other semiconductor companies to new heights. NVDA 1Y line Khodjamirian noted that Nvidia is "setting the pace" in the industry with annual product announcements that competitors struggle to match. Ginsberg predicts that Fortune 500 companies will increasingly outsource their AI and algorithmic business to cloud service providers, benefiting companies like Google Cloud and Microsoft Cloud.

Persons: Yuri Khodjamirian, CNBC's, Nvidia's, Microsoft's –, Khodjamirian, Anthony Ginsberg, Ginsberg, Satya Nadella, Sundar Pichai Organizations: Nvidia, Microsoft, Google, Apple, Gins, Tech, CNBC Pro, Amazon Locations: America

☆ Nvidia is 'really pushing the pace,' Tema ETFs CIO says
▼ + stars: | 2024-06-07 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNvidia is 'really pushing the pace,' Tema ETFs CIO saysYuri Khodjamirian, chief investment officer of Tema ETFs, discusses the investment outlook for Nvidia, shortly after the chipmaking behemoth surpassed Apple as the world’s second-most valuable public company.

Persons: Yuri Khodjamirian Organizations: Nvidia, Apple Locations: Tema

☆ Rolls-Royce is growing its factory so it can build cars more slowly
▼ + stars: | 2024-04-28 | by ( Peter Valdes-Dapena | ) edition.cnn.com time to read: +5 min

So this factory expansion isn’t about making more cars, but making more expensive cars, which takes more time and requires more space for workshops and storage of exotic materials. The Rolls-Royce Phantom Syntopia's has glass flecks to create sparkling designs. Before that, Rolls-Royce cars were built alongside Bentleys — Rolls-Royce had acquired Bentley in 1931 — at a factory in Crewe, UK. The Phantom Syntopia likely would have cost more than $3 million according to sources, although Rolls-Royce would not confirm an exact price. The Phantom Syntopia has a special Weaving Water design in its Starlight Headliner.

Persons: Royce, “ We’re, ”, Martin Fritsches, “ That’s, Bentleys —, Bentley, Stephan Winkelmann, Javier Gonzalez Lastra, Fritsches, Cullinan Organizations: CNN, BMW, Royce, Bentley, Volkswagen, Lamborghini, Ferrari, ” Lamborghini, Tema Locations: Chichester , England, Crewe, cabinetry

☆ LVMH's report could've been a lot worse, says Javier Gonzalez Lastra
▼ + stars: | 2024-04-17 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLVMH's report could've been a lot worse, says Javier Gonzalez LastraJavier Gonzalez Lastra, Investment Partner and Portfolio Manager at Tema Luxury ETF, discusses earnings from LVMH.

Persons: could've, Javier Gonzalez Lastra Javier Gonzalez Lastra Organizations: Investment

☆ The CEO of a weight-loss ETF that's crushing the S&P 500 since launching in November shares 4 stocks he sees with over 100% upside in the next 12 months
▼ + stars: | 2024-04-04 | by ( William Edwards | ) www.businessinsider.com time to read: +5 min

Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are all the rage, and investors are noticing. Since launching in November, the Tema Obesity and Cardiometabolic ETF (HRTS) is up 24%, crushing the S&P 500's 14.8% returns over the same period. Pot and his colleagues at Tema are bullish on the weight-loss drug stocks due to the wave of demand they see coming. Novo Nordisk estimates that only 2% of obesity cases are being treated by weight-loss drugs, Pot said. 4 weight-loss drug stocks to watchPot listed two larger stocks and two smaller ones in the space.

Persons: Maurits Pot, Janus Henderson, Pot, Goldman Sachs, Geoff Meacham, Charles Barkley, Elon Musk, Whoopi Goldberg, Eli Lilly, Lilly Organizations: VanEck Pharmaceutical, Business, World Health Organization, Novo Nordisk, Bank of America, Bank, Nordisk, FDA, Amazon, Therapeutics, Zealand Pharma Locations: Tema, GLP, Danish, it's

☆ AI could fuel factory reshoring to developed markets, says CIO of Tema ETF
▼ + stars: | 2024-03-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAI could fuel factory reshoring to developed markets, says CIO of Tema ETFAI could push companies to bring manufacturing back to developed economies as the labor cost arbitrage opportunity shrinks, according to Yuri Khodjamirian, chief investment officer of Tema ETF. This trend has also driven up shares of construction materials stocks, he added.

Persons: Yuri Khodjamirian Locations: Tema

☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
▼ + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.

Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly

☆ 'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights
▼ + stars: | 2024-02-19 | by ( Michelle Fox | ) www.cnbc.com time to read: +14 min

There's been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Attention to a long-time crisis The mental health crisis is nothing new. However, there has also been a growing awareness and acceptance of mental health illnesses over the past decade, said Canaccord Genuity analyst Richard Close. "There's been recognition that mental health has a significant impact on a person's overall health," he said. "This is the mental health moment," said Dr. Ken Duckworth, NAMI's chief medical officer and author of "You Are Not Alone: The NAMI Guide to Mental Health."

Persons: There's, Covid, Peter Micca, AbbVie, Emraclidine, Myers Squibb, Karuna, Marc Goodman, Canaccord, Richard Close, MacKenzie Scott, Ken Duckworth, NAMI, Deloitte's Micca, William Blair, Myles Minter, Minter, Auvelity, Leerink's Goodman, Ashwani Verma, Verma, Goodman, BioHaven, Cerevel, Neumora, tardive, David Song, BetterHelp, psychedelics Johnson, Johnson, Spravato, Blair's Minter, Axsome, Micca, Michael Bloom Organizations: Institute for Health Metrics, Deloitte, Cerevel Therapeutics, Karuna Therapeutics, Bristol Myers, Leerink Partners, Centers for Disease Control, National Alliance, Mental, Mental Health, Wall Street, Therapeutics, Neumora Therapeutics, UBS, Karuna, Cellular Therapies, Xenon Pharmaceuticals, Neurocrine Biosciences, Acadia Pharmaceuticals, Tema Neuroscience, Axsome Therapeutics, Acadia Healthcare, BetterHelp, CNBC, pharma, Cellular Locations: Covid, Bristol, XEN1101, Acadia, Tema

Search resuls for: "TEMA"

25 mentions found